Cargando…

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma

BACKGROUND: Gastric adenocarcinoma (GAD) is one of the most common tumors in the world and the prognosis is still very poor. OBJECTIVE: We sought to identify reliable prognostic biomarkers for the progression of GAD and the sensitivity to drug therapy. METHOD: The RNA sequencing data of GAD was down...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiaowen, Wu, Pingfan, Liu, Dongling, Li, Changtian, Xue, Ling, Liu, Zhe, Zhu, Meng, Yang, Jie, Chen, Ziyi, Li, Yaling, She, Yali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061059/
https://www.ncbi.nlm.nih.gov/pubmed/35509706
http://dx.doi.org/10.1155/2022/3035073
_version_ 1784698644420624384
author Zhao, Xiaowen
Wu, Pingfan
Liu, Dongling
Li, Changtian
Xue, Ling
Liu, Zhe
Zhu, Meng
Yang, Jie
Chen, Ziyi
Li, Yaling
She, Yali
author_facet Zhao, Xiaowen
Wu, Pingfan
Liu, Dongling
Li, Changtian
Xue, Ling
Liu, Zhe
Zhu, Meng
Yang, Jie
Chen, Ziyi
Li, Yaling
She, Yali
author_sort Zhao, Xiaowen
collection PubMed
description BACKGROUND: Gastric adenocarcinoma (GAD) is one of the most common tumors in the world and the prognosis is still very poor. OBJECTIVE: We sought to identify reliable prognostic biomarkers for the progression of GAD and the sensitivity to drug therapy. METHOD: The RNA sequencing data of GAD was downloaded from the Cancer Genome Atlas (TCGA) database and used for analysis. Differentially expressed, immune-related lncRNA (DEIRlncRNA) was characterized by differential analysis and correlation analysis. Univariate Cox regression analysis was used to identify DEIRlncRNA associated with prognosis. Least absolute shrinkage and selection operator (LASSO) regression analysis allowed us to determine a signature composed of eight IRlncRNAs. Based on this signature, we further performed gene set enrichment analysis (GSEA) and somatic mutation analysis to evaluate the ability of this signature to predict prognosis. RESULTS: In total, 72 immune-related lncRNAs (DEIRlncRNAs) with prognostic value were identified. These lncRNAs were used to construct a model containing eight immune-related lncRNAs (8-IRlncRNAs). Based on this risk model, we divided GAD patients into high-risk and low-risk groups. The analysis showed that the prognosis of the two groups was different and that the high-risk group had worse overall survival (OS). Immune cell infiltration analysis showed that the proportion of memory B cells increased in the high-risk group while the proportion of macrophages M1, T cells, CD4 memory-activated cells, and T cell follicular helpers decreased. GSEA results showed that 8-IRlncRNA was significantly enriched in tumorigenesis pathways such as myc. The results of somatic mutation analysis showed that the CDH1 gene was significantly mutated in the high-risk group. CONCLUSION: A prognostic signature of 8-IRlncRNAs in GAD was established and this signature was able to predict the prognosis of GAD patients.
format Online
Article
Text
id pubmed-9061059
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90610592022-05-03 An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma Zhao, Xiaowen Wu, Pingfan Liu, Dongling Li, Changtian Xue, Ling Liu, Zhe Zhu, Meng Yang, Jie Chen, Ziyi Li, Yaling She, Yali J Healthc Eng Research Article BACKGROUND: Gastric adenocarcinoma (GAD) is one of the most common tumors in the world and the prognosis is still very poor. OBJECTIVE: We sought to identify reliable prognostic biomarkers for the progression of GAD and the sensitivity to drug therapy. METHOD: The RNA sequencing data of GAD was downloaded from the Cancer Genome Atlas (TCGA) database and used for analysis. Differentially expressed, immune-related lncRNA (DEIRlncRNA) was characterized by differential analysis and correlation analysis. Univariate Cox regression analysis was used to identify DEIRlncRNA associated with prognosis. Least absolute shrinkage and selection operator (LASSO) regression analysis allowed us to determine a signature composed of eight IRlncRNAs. Based on this signature, we further performed gene set enrichment analysis (GSEA) and somatic mutation analysis to evaluate the ability of this signature to predict prognosis. RESULTS: In total, 72 immune-related lncRNAs (DEIRlncRNAs) with prognostic value were identified. These lncRNAs were used to construct a model containing eight immune-related lncRNAs (8-IRlncRNAs). Based on this risk model, we divided GAD patients into high-risk and low-risk groups. The analysis showed that the prognosis of the two groups was different and that the high-risk group had worse overall survival (OS). Immune cell infiltration analysis showed that the proportion of memory B cells increased in the high-risk group while the proportion of macrophages M1, T cells, CD4 memory-activated cells, and T cell follicular helpers decreased. GSEA results showed that 8-IRlncRNA was significantly enriched in tumorigenesis pathways such as myc. The results of somatic mutation analysis showed that the CDH1 gene was significantly mutated in the high-risk group. CONCLUSION: A prognostic signature of 8-IRlncRNAs in GAD was established and this signature was able to predict the prognosis of GAD patients. Hindawi 2022-04-25 /pmc/articles/PMC9061059/ /pubmed/35509706 http://dx.doi.org/10.1155/2022/3035073 Text en Copyright © 2022 Xiaowen Zhao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhao, Xiaowen
Wu, Pingfan
Liu, Dongling
Li, Changtian
Xue, Ling
Liu, Zhe
Zhu, Meng
Yang, Jie
Chen, Ziyi
Li, Yaling
She, Yali
An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
title An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
title_full An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
title_fullStr An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
title_full_unstemmed An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
title_short An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
title_sort immunity-associated lncrna signature for predicting prognosis in gastric adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061059/
https://www.ncbi.nlm.nih.gov/pubmed/35509706
http://dx.doi.org/10.1155/2022/3035073
work_keys_str_mv AT zhaoxiaowen animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT wupingfan animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT liudongling animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT lichangtian animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT xueling animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT liuzhe animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT zhumeng animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT yangjie animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT chenziyi animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT liyaling animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT sheyali animmunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT zhaoxiaowen immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT wupingfan immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT liudongling immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT lichangtian immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT xueling immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT liuzhe immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT zhumeng immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT yangjie immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT chenziyi immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT liyaling immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma
AT sheyali immunityassociatedlncrnasignatureforpredictingprognosisingastricadenocarcinoma